Aardvark Therapeutics, Inc. (AARD) Form 10-K Annual Reports
Aardvark Therapeutics, Inc. (AARD) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AARD
CIK: 1774857
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
BDO USA, P.C.
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerSamuel Najewicz
Audit LocationSan Diego, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-08 | 2026-10-07 | 4 | 0001193125-26-418022 | View SEC Doc Filr Page |
| 3 | 2026-10-08 | 2026-10-07 | 3 | 0001193125-26-418016 | View SEC Doc Filr Page |
| 8-K | 2026-10-08 | 2026-10-06 | 8-K | 0001193125-26-417935 | View SEC Doc Filr Page |
| 4 | 2026-09-11 | 2026-09-10 | 4 | 0001193125-26-389564 | View SEC Doc Filr Page |
| 144 | 2026-09-11 | — | 144 Filing | 0001950047-26-009373 | View SEC Doc Filr Page |
| 144 | 2026-09-10 | — | 144 Filing | 0001950047-26-009316 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-14 | 4 | 0001193125-26-361489 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-14 | 4 | 0001193125-26-361486 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-14 | 4 | 0001193125-26-361482 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-14 | 4 | 0001193125-26-361481 | View SEC Doc Filr Page |
| 8-K | 2026-08-17 | 2026-08-14 | 8-K | 0001193125-26-354053 | View SEC Doc Filr Page |
| 10-Q | 2026-08-11 | 2026-06-30 | 10-Q | 0001193125-26-344987 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001193125-26-344978 | View SEC Doc Filr Page |
| ARS | 2026-07-10 | 2025-12-31 | ARS | 0001193125-26-300897 | View SEC Doc Filr Page |
| DEF 14A | 2026-07-10 | 2026-08-14 | DEF 14A | 0001193125-26-300874 | View SEC Doc Filr Page |
| PRE 14A | 2026-06-29 | 2026-08-14 | PRE 14A | 0001193125-26-288409 | View SEC Doc Filr Page |
| 8-K | 2026-06-12 | 2026-06-10 | 8-K | 0001193125-26-269377 | View SEC Doc Filr Page |
| 8-K | 2026-05-14 | 2026-05-14 | 8-K | 0001193125-26-224069 | View SEC Doc Filr Page |
| 10-Q | 2026-05-07 | 2026-03-31 | 10-Q | 0001193125-26-210675 | View SEC Doc Filr Page |
| 8-K | 2026-05-07 | 2026-05-07 | 8-K | 0001193125-26-210664 | View SEC Doc Filr Page |
| EFFECT | 2026-04-03 | — | EFFECT Filing | 9999999995-26-001083 | View SEC Doc Filr Page |
| 424B5 | 2026-04-03 | — | 424B5 | 0001193125-26-142105 | View SEC Doc Filr Page |
| CORRESP | 2026-03-30 | — | CORRESP Filing | 0001193125-26-131825 | View SEC Doc Filr Page |
| UPLOAD | 2026-03-25 | — | UPLOAD Filing | 0000000000-26-003024 | View SEC Doc Filr Page |
| 8-K | 2026-03-24 | 2026-03-23 | 8-K | 0001193125-26-120164 | View SEC Doc Filr Page |